The contraindications for a dipyridamole nuclear stress test, according to guidelines from the American Society of Nuclear Cardiology,

**(1)**If a patient has bronchospastic lung disease with ongoing wheezing or significant reactive airway disease.

**(2)**If a patient presents with systolic blood pressure less than 90 mmHg. (The risk of serious hypotension may be higher in patients with autonomic dysfunction, hypovolemia, stenotic valvular disease)

**(3)**If the patient has uncontrolled hypertension, defined by a systolic blood pressure greater than 200 mmHg and/or diastolic blood pressure of 110 mmHg.

**(4)**If the patient has consumed caffeinated foods, beverages, or drugs within 12 hours of the scheduled test.

**(5)**If the patient has a known hypersensitivity to dipyridamole.

**(6)**If the patient has unstable angina or acute coronary syndrome; or has had an acute myocardial infarction within 4 days of the scheduled test.

The relative contraindications for a dipyridamole nuclear stress test, according to guidelines American Society of Nuclear Cardiology,

**(1)**If the patient presents with sinus bradycardia (i.e., heart rate of fewer than 40 beats per minute.

**(2)**If the patient has a second-degree or third-degree atrioventricular block without a functioning pacemaker.

**(3)**If the patient has severe aortic stenosis.

**(4)**If the patient is prone to seizures.